Inari Medical
Clinical trials sponsored by Inari Medical, explained in plain language.
A medical device company focused on treating venous diseases.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New device aims to unclog stents in leg veins Results expected Apr 2027 (estimated)
-
New device aims to improve survival and reduce hospital stays for lung clot patients
Disease control OngoingThis study compares a device called FlowTriever (used with blood thinners) to blood thinners alone for people with intermediate-risk pulmonary embolism (blood clots in the lungs). About 1,200 adults with clots in major lung arteries and signs of heart strain will be randomly assi…
Sponsor: Inari Medical • Aim: Disease control
Last updated Sep 13, 2026 00:00 UTC
-
New Clot-Removing device tested in japan for dangerous blood clots
Disease control By invitation onlyThis study is tracking 100 patients in Japan who receive the ClotTriever device to treat severe deep vein thrombosis (DVT). The device is used to remove blood clots from deep veins. Researchers are checking how safe the device is and how well it clears the clot in everyday hospit…
Sponsor: Inari Medical • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC